# LifeStance Health Group, Inc. (LFST) FY2026 Q2 Balance Sheet

- Company: LifeStance Health Group, Inc. (LFST)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001193125-26-338107
- Page: https://plicit.ai/financials/lfst/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/lfst-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,181,496,000 US dollars
- **Current assets**: 377,966,000 US dollars
- **Non-current assets**: 1,803,530,000 US dollars
- **Liabilities**: 704,348,000 US dollars
- **Current liabilities**: 274,753,000 US dollars
- **Non-current liabilities**: 429,595,000 US dollars
- **Equity**: 1,477,148,000 US dollars
- **Cash and cash equivalents**: 225,943,000 US dollars
- **Patient accounts receivable, net**: 110,960,000 US dollars
- **Prepaid expenses and other current assets**: 41,063,000 US dollars
- **Goodwill**: 1,304,556,000 US dollars
- **Intangible assets, net**: 172,805,000 US dollars
- **Property and equipment, net**: 164,696,000 US dollars
- **Right-of-use assets**: 157,007,000 US dollars
- **Other noncurrent assets**: 4,466,000 US dollars
- **Accrued payroll expenses**: 149,320,000 US dollars
- **Other accrued expenses**: 49,551,000 US dollars
- **Operating lease liabilities, current**: 46,500,000 US dollars
- **Other current liabilities**: 18,329,000 US dollars
- **Accounts payable**: 11,053,000 US dollars
- **Long-term debt, net**: 258,991,000 US dollars
- **Operating lease liabilities, noncurrent**: 154,159,000 US dollars
- **Deferred tax liability, net**: 16,408,000 US dollars
- **Other noncurrent liabilities**: 37,000 US dollars
- **Additional paid-in capital**: 2,244,099,000 US dollars
- **Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2026 and December 31, 2025; 382,022 and 388,318 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 3,820,000 US dollars
- **Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30,2026 and December 31, 2025; 0 shares issued and outstanding as of june 30,2026 and December 31,2025, respectively**: 0 US dollars
- **Accumulated deficit**: negative 770,771,000 US dollars
- **Gross equity (calculated)**: 2,247,919,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.